Abstract-Biomedical implantable sensors transmitting a variety of physiological signals have been proven very useful in the management of chronic diseases. Currently, the vast majority of these in-body wireless sensors communicate in frequencies below 1 GHz. Although the radio propagation losses through biological tissues may be lower in such frequencies, e.g., the medical implant communication services band of 402 to 405 MHz, the maximal channel bandwidths allowed therein constrain the implantable devices to low data rate transmissions. Novel and more sophisticated wireless in-body sensors and actuators may require higher data rate communication interfaces. Therefore, the radio spectrum above 1 GHz for the use of wearable medical sensing applications should be considered for in-body applications too. Wider channel bandwidths and smaller antenna sizes may be obtained in frequency bands above 1 GHz at the expense of larger propagation losses. Therefore, in this paper, we present a phantom-based radio propagation study for the frequency bands of 2360 to 2400 MHz, which has been set aside for wearable body area network nodes, and the industrial, scientific, medical band of 2400 to 2483.5 MHz. Three different channel scenarios were considered for the propagation measurements: in-body to in-body, in-body to on-body, and in-body to off-body. We provide for the first time path loss formulas for all these cases.
the exceptions since multiple applications of radio technologies have had a beneficial impact on the way diagnosis and therapeutic procedures are performed [1] . In the same vein, the use of radio communications combined with biomedical sensors for the continuous monitoring of patients suffering from chronic diseases has gained significant attention as these solutions promise to lower the global expenditure in healthcare [2] [3] [4] . The interconnection of such wireless biomedical sensors to form a body area network (BAN) has been standardized in IEEE Std 802.15.6-2012 [5] , which specifies the physical (PHY) and medium access control layers for communication on the surface, inside, or in the peripheral proximity of the human body. According to this standard, wearable BAN nodes can communicate in existing industrial, scientific, medical (ISM) bands, as well as other frequency bands approved by national medical and/or regulatory authorities. These include the frequency band of 2360-2400 MHz [6] , [7] , which the United States Federal Communications Commission has set aside for medical wearable sensors in order to complement the already crowded 2400-2483.5-MHz ISM band (simply referred to as the 2.4-GHz ISM band). However, as specified by IEEE Std 802.15.6-2012, in-body BAN nodes can communicate in the medical implant communication services (MICS) band only, i.e., 402-405 MHz [7] [8] [9] [10] . Although the expected radio propagation losses through biological tissues in the MICS band may not be as high as within 2360-2400 or 2400-2483.5 MHz, the maximal channel bandwidth of 300 kHz allowed in the MICS band constrains the implantable devices to low data rate transmissions. Therefore, a number of other frequency bands have been considered for communication interfaces with medical implants and in-body electronic pills [11] [12] [13] . Wider channel bandwidths for novel and more sophisticated in-body wireless sensors and actuators may be exploited in frequency bands above 1 GHz at the expense of larger propagation losses. Despite this drawback, the feasibility of using the radio spectrum above 1 GHz for inbody BAN applications should be investigated because utilizing higher frequencies can also reduce the physical dimensions of implantable antennas that may facilitate the further miniaturization of in-body BAN nodes. For instance, some of the 39 channels of 1-MHz bandwidth available in 2360-2400 MHz could be employed for implant communications besides their intended application as on-body radio interfaces; 79 similar channels are available in the 2.4-GHz ISM band [7] . The idea of using the spectrum around 2.4 GHz for communication with in-body BAN nodes has been proposed before, and a variety of implantable antennas for this purpose have been designed, e.g., [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . In addition, propagation losses of body implanted antennas were computed via numerical simulations with single-and three-layer tissue structures for the different ISM bands, namely 433, 915, 2450, and 5800 MHz in [25] . However, no mathematical formulas for the path loss (PL) were provided in that study. On the other hand, numerical and experimental PL investigations with ingested wireless implants in 402, 868, and 2400 MHz were presented in [26] . A log-distance PL formula as a function of the propagation distance d was introduced for the in-body to onbody (IB2OB) channel scenario. In this model, the PL exponent γ, which indicates the rate at which the PL increases with d had a value of 2.8 and 2.6 for data obtained from phantom measurements and numerical simulations at 2.4 GHz, respectively. Likewise, measurements in a phantom and numerical simulations of PL for insulated dipole antennas in the ISM band at 2.457 GHz led to PL formulas for the in-body to in-body (IB2IB) channel scenario [27] , [28] . In spite of all these research efforts, no comprehensive set of PL models stemming from measurements or simulations in a single propagation medium for all the possible channel scenarios involving in-body BAN nodes has been reported in the literature. Therefore, to fill this gap, we present a radio propagation study for 2360-2500 MHz, which covers the two frequency bands discussed previously with potential use for implant communications. We performed channel measurements in a liquid phantom, i.e., a chemical solution specially formulated to reproduce the dielectric properties of human muscle tissues [29] . We considered three different channel scenarios: IB2IB, IB2OB, and in-body to off-body (IB2OFF). We provide for the first time the PL formulas for all these cases.
The remainder of the paper is organized as follows. In Section II, we describe the experimental setup and measurement methodology. Section III presents the PL formulas for the different in-body channel scenarios. In Section IV, we discuss the implications of our findings for the implementation of implant communications in 2.36-2.5 GHz. Finally, Section V summarizes our conclusions.
II. EXPERIMENTAL SETUP AND MEASUREMENT METHODOLOGY

A. In-Body Channel Scenarios
The in-body channel scenarios that we considered herein combined the three possible locations of BAN nodes that the Channel Modeling Subgroup of IEEE Std 802.15.6-2012 identified in [30] . Hence, these in-body channel scenarios can be described as follows.
1) IB2IB, a link between two implanted nodes.
2) IB2OB, a link between an implanted node and a node in direct contact with the skin or within 2-cm distance. 3) IB2OFF, a link between an implanted node and a node beyond 2 cm and up to 5 m from the body surface. Nevertheless, because of the limitations imposed by the physical size and construction of the phantom, the channel measurements were performed with the best possible approximation to the characteristics of each scenario. Note that in this case the two implantable antennas were located along an imaginary diagonal line that divided the phantom in two triangular halves. This was done in order to obtain a larger transmission range. However, in the other two cases, i.e., IB2OB and IB2OFF, an implantable antenna and the helical antenna were located along an imaginary line that divided the phantom in two rectangular halves.
B. Experimental Setup
The setup used for the IB2IB measurements is shown in Fig. 1 , which consisted of a vector network analyzer (VNA), a cube-shaped container, phantom aqueous solution, two insulated dipole antennas, and two coaxial cables. For the IB2OB and IB2OFF measurements, one of the insulated dipoles was replaced with a free-space coax fed helical antenna with a dielectric support on a finite ground plane and six turns of copper wire. This free-space helical antenna exhibited a reflection coefficient of |S 11 | < −10 dB within 2.36-2.5 GHz and a gain of 7.7 dB at 2.4 GHz. The physical dimensions of these antennas are shown in Fig. 2 . The antennas were connected to an Agilent Technologies ENA E5072A VNA, which had a maximal operation frequency of 8.5 GHz. Two coaxial cables of 1 m in length with a maximal operation frequency of 12.4 GHz were used to connect the antennas to the VNA ports 1 and 2, respectively. The cables' frequency response was subtracted from the channel measurements by performing a careful thru-calibration of the VNA. Further details about some components of this measurement setup are given below.
C. Phantom Aqueous Solution
In order to approximate the propagation conditions of the human body within 2.36-2.5 GHz, an aqueous solution of sucrose (C 12 H 22 O 11 ) and sodium chloride (NaCl) was prepared. Reportedly, a solution with the following weight proportions: 59.5% of deionized water, 40% of sucrose, and 0.5% of sodium chloride, approximates the dielectric characteristics of human muscle tissues at 2.45 GHz, i.e., relative permittivity ε r = 52.7 and conductivity σ = 1.73 S/m [24] . However, slight changes in these dielectric parameters may occur because of ambient temperature variations. The prepared solution was poured into a cube-shaped container made of extruded polystyrene foam (Styrofoam) with wall thickness w th of 40 mm. The container's size was 30 × 30 × 20 cm 3 (width × length × height), and the phantom solution occupied a volume of 22 × 22 × 16 cm 3 . Hereinafter, we refer to this arrangement as "the phantom."
D. Insulated Dipole Antennas
The insulated dipoles were designed with arms made of a perfect electric conductor material surrounded by an insulation made of polytetrafluoroethylene (ε r = 2.07 and σ = 0 S/m) [27] , [28] ; in the physical implementation [see Fig. 2(a) ], however, the arms were made of copper. These antennas were originally designed to resonate at 2.457 GHz when submerged in a phantom solution with ε r = 50.8 and σ = 2.01 S/m. However, through measurements of the reflection coefficient, i.e., |S 11 | parameter, we verified that the insulated dipoles covered properly the 2.36-2.5-GHz frequency band when submerged in our liquid phantom described previously (see Fig. 3 ).
E. Measurement Methodology
The measurements consisted of obtaining the forward channel gain in the frequency domain, i.e., S 21 (f ), within the band under analysis. Measurements were performed between 2.36 and 2.5 GHz with N = 20001 resolution points; thus, the frequency resolution was Δf = 7 kHz. The VNA output power was set to 10 dBm and the noise floor was at −110 dBm within a bandwidth f IF = 3 kHz. All the measured data were recorded for processing and analysis in MATLAB. Five snapshots of the channel were recorded to improve the signal-to-noise ratio. The PL in decibel was then calculated as PL = −mean {S 21 (f )}. For each channel scenario, a discrete number of PL points versus the corresponding distance separating the antennas, i.e.,PL (d i ), were plotted, and a continuous curve was fitted to the resulting scatter plot. The least-square fitting method was then used to produce a PL formula as a function of distance.
III. PL FORMULAS
A. IB2IB Channel Scenario
In this scenario, the two insulated dipoles were submerged in the phantom so that the center of each antenna was located at 8 cm of depth aligned vis-à-vis in a copolarized mode. An antenna was fixed at a distance of 4 cm from the phantom's internal edge, whereas the second one was moved away from a starting distance d = 20 mm up to d = 140 mm in steps of 10 mm (see Fig. 4 ).
The respective discrete scatter plots of PL (d i ) for the frequency bands of 2.36-2.4 and 2.4-2.5 GHz are shown in Fig. 5 . As seen, the difference in PL between these two bands is negligible for all the considered distance points. Therefore, in order to produce a PL formula, the channel measurements were averaged over the entire frequency range of 2.36-2.5 GHz. The resulting scatter plot and fitted curve for 2.36-2.5 GHz are shown in Fig. 6 .
In this case, the mathematical model (fitted curve) for the PL in decibel as a function of d in millimeters is a linear equation given as
where PL 0 is an initial PL value in decibel observed in the limit when d → 0, and α is a scaling factor. Here, PL 0 = 11.9 dB and α = 0. in [27] and [28] , where IB2IB PL formulas valid for 5 ≤ d ≤ 80 mm were introduced.
B. IB2OB Channel Scenario
In this scenario, one insulated dipole was submerged in the phantom, whereas the helical antenna [see Fig. 2(b) ] was facing it at the same height in direct contact with the external phantom's wall. We denoted the distance from the insulated dipole to the phantom's internal wall as d in . Note that in this case, the effective distance separating the two antennas in millimeters including the phantom's wall thickness w th is
However, we measured the PL through the 40-mm-thick Styrofoam wall and found it to be negligible; therefore, one can assume that
In a real-life IB2OB scenario, where a wearable sensor is in direct contact with a patient's skin, d in = d and (3) may become PL (d in ) = PL (d). Thus, the helical antenna was kept fixed, whereas d in was varied by moving the dipole away in steps of 10 mm as shown in Fig. 7 . The scatter plot and fitted curve as a function of d in for 2.36-2.5 GHz are shown in Fig. 8 . A linear equation of the same form as (1) is Note that for the same distance value, a larger PL is observed in the IB2OB channel scenario when compared to IB2IB. This additional loss is a direct result of the impedance mismatch caused by the change of propagation medium along the propagation path [31] [32] [33] .
C. IB2OFF Channel Scenario
The measurement setup for the IB2OFF scenario is similar to that of IB2OB, but here the insulated dipole was fixed at a distance d in as in the previous scenario, whereas the helical antenna was moved away from the phantom. We denoted the distance from the phantom's internal wall to the helical antenna as d off (see Fig. 9 ). We considered three different fixed values for d in : 10, 20, and 30 mm. For each of these cases, we put the helical antenna at multiple locations so that d off varied from 40 to 540 mm. The resulting scatter plots and fitted curves as functions of d off for 2.36-2.5 GHz are presented in Fig. 10 .
In this scenario, the fitted curve for the PL in each case follows a log-distance formula expressed in decibel as
where γ is a PL exponent and d ref is a reference distance equal to 1 mm. The subscript d in in (4) indicates that the formula is valid for one of the three specific values of d in considered herein; the corresponding values of PL 0 and γ for these three cases are given in Table I . As expected, in this scenario, the wave propagation through the aqueous phantom solution was the largest contributor to the total PL along d. This can be observed by comparing Figs. 8 and  10 , where it is evident that the rate at which the PL increases with distance is significantly lower in the air. As hinted in [30] , the PL in the IB2OFF channel scenario can be approximated by considering a combination of IB2OB and indoor PL models; when no surrounding objects and obstacles are present, then simply the free-space loss can be added to the IB2OB PL.
IV. DISCUSSION
The set of PL formulas presented above are aimed to provide some insight into the behavior of the different in-body channel scenarios to assist the biomedical engineer in the early stage of the design of wireless implantable sensors. It is clear that these PL models are antenna dependent as the vast majority of other BAN propagation models proposed in the literature. As the wavelength of the propagating signal in the phantom aqueous solution is λ = 17 mm, some of the measurements were inevitably performed within the reactive near-field of each dipole antenna, the boundary of which is R = 36 mm. However, implantable and free-space antennas with |S 11 | < −10 dB were used in all the channel scenarios to try to counter as much as possible the antenna effects on the PL. Although channel measurements in a homogeneous propagation medium like an aqueous phantom solution do not fully capture the effects of propagation through inhomogeneous multilayer structures like the human body, they provide practical rules of thumb to assess the feasibility of establishing reliable communications for some implantable biomedical applications within 2.36-2.5 GHz.
For instance, consider the ultralow power radio system for BAN applications designed in [34] , which can operate in 2.36-2.4 and the 2.4 GHz ISM band. The transmitter (Tx) of this system utilizes a basic on-off keying modulation scheme with 0 dBm peak power. Including the Tx baseband, the Tx power consumption is 4.243 mW when transmitting a logical "1" and 0.919 mW for a logical "0." The receiver (Rx) front end achieves a sensitivity of −75 dBm at 5 Mb/s and −78 dBm at 3 Mb/s. Therefore, if this radio system is equipped with properly matched implantable/on-body antennas accordingly, the maximal transmission range that may be attained for the different in-body scenarios can be estimated with the PL formulas we provided.
From (1), it follows that for IB2IB, the maximal transmission range of this BAN system is 90 and 94 mm for 5 and 3 Mb/s, respectively. These transmission ranges are suitable for some communication applications in the thoracic cavity, e.g., wireless sensing for a subcutaneous implantable cardioverterdefibrillator (s-ICD) [35] , [36] . An implanted cardiovascular pressure monitor integrated with a medical stent [37] could send an alert signal on a wireless interface within 2360-2483.5 MHz to the s-ICD in order to deliver transthoracic shocks when ventricular tachyarrhythmias are detected.
Similarly, for IB2OB, the maximal transmission range is 75 and 80 mm for 5 and 3 Mb/s, respectively. These transmission ranges represent the maximal implantation depths from the skin for the wireless sensors. Hence, applications like the insertableloop recorder [38] and continuous glucose monitoring systems [39] could also benefit from smaller antenna sizes by using radio interfaces within 2360-2483.5 MHz. Since these applications utilize a subcutaneous wireless sensor, i.e., a sensor implanted just under the patient's skin, the transmission range could likely be extended to IB2OFF for communication with a hand-held patient assistant unit to display, analyze, and record the physiological data. On the other hand, the above transmission ranges for IB2OB within 2360-2483.5 MHz may not fulfill the transmission range requirements for some electronic pill applications like the wireless capsule endoscope (WCE) [11] . In this biomedical application, the transmission range varies widely as the WCE travels inside the gastrointestinal tract transmitting images to a belt receiver/recorder that the patient has to wear during the entire endoscopic procedure (approximately 8 h). An average transmission range of 200 mm is typically required for a WCE procedure, but up to 500 mm may be needed in some cases. Therefore, practical solutions like the use of a matching layer and spatial diversity reception that have been studied in the context of ultrawideband WCE [40] [41] [42] should be also investigated for 2360-2483.5 MHz.
Nevertheless, the designer of an implantable communication link using our PL models has to take into account the fact that miniaturized implantable antennas may not be so well matched to the medium as the dipoles used in our measurements. Implantable antenna mismatch and other varying factors like the different thicknesses of fat layer of the patients require the addition of a link budget margin to the PL calculation. The value of such margin is generally determined based on practical prototype tests.
V. CONCLUSION
We have presented a collection of PL models for 2.36-2.5 GHz derived from measurements in a liquid phantom that reproduced the dielectric characteristics of human muscle tissues. These results provide useful insight into the behavior of the different radio channel scenarios for implant communications. However, the fact that the measurements were performed using a homogeneous propagation medium leaves some room for improvement. Therefore, our future work considers the performance of in vivo channel measurements in an animal subject. Such a measurement campaign will allow capturing the effects of blood circulation, respiration, and temperature gradients on the PL for the different in-body channel scenarios, which are not properly modeled in most cases; even numerical simulations using digital anatomical models often fail to capture these effects. From the experience gained after multiple in vivo tests of implantable radio transceivers at the Intervention Centre, Oslo University Hospital [43] , [44] , we have concluded that channel measurements on a living porcine subject can produce PL formulas that fairly approximate the propagation characteristics in the human torso. It will be necessary, however, to perform the measurements using various types of antennas with significantly variable sizes in order to fully validate the parameters of the formulas presented in this paper.
Our current PL models for the different in-body channel scenarios indicate that radio interfaces within 2.36-2.5 GHz are feasible for some implantable biomedical sensors. The use of these frequency bands can promote further miniaturization of the antennas, a very important design aspect for biomedical implants. At the same time, wider channel bandwidths will be available for the transmission of larger amounts of physiological data. The design of radio transceivers for implants operating within 2.36-2.5 GHz will be a part of our future research activities too. Optimal transceiver design, however, calls for more accurate characterization of the different in-body radio channel scenarios. Hence, this study could contribute to spark further research interest toward the exploitation of this portion of the spectrum for implant communications.
